PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, DaVita's PE Ratio without NRI is 16.35. DaVita's 5-Year EBITDA growth rate is 14.90%. Therefore, DaVita's PEG Ratio for today is 1.10.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for DaVita's PEG Ratio or its related term are showing as below:
DVA'
s PEG Ratio Range Over the Past 10 Years
Min: 0.6 Med: 1.59 Max: 3.03
Current: 1.1
During the past 13 years, DaVita's highest PEG Ratio was 3.03. The lowest was 0.60. And the median was 1.59.
DVA's PEG Ratio is ranked better than 62.84% of 218
companies
in the Healthcare Providers & Services industry
Industry Median: 1.55
vs DVA: 1.10
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
DaVita PEG Ratio Historical Data
The historical data trend for DaVita's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
DaVita Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
PEG Ratio
1.61
1.59
1.15
0.74
0.84
DaVita Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
PEG Ratio
0.74
0.78
1.07
0.84
0.84
Competitive Comparison
For the Medical Care Facilities subindustry, DaVita's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita PEG Ratio Distribution
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's PEG Ratio distribution charts can be found below:
* The bar in red indicates where DaVita's PEG Ratio falls into.
DaVita PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
DaVita (NYSE:DVA) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
DaVita PEG Ratio Related Terms
Thank you for viewing the detailed overview of DaVita's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVA has been successfully added to your 